Interleukin-6 inhibits voltage-gated sodium channel activity of cultured rat spinal cord neurons

Acta Neuropsychiatrica

Volumn 26, Issue 3, 2014, Pages 170-177

  Li, Xiaoning ^a,b   Chen, Weiqiang ^b   Sheng, Jiangtao ^b   Cao, Deliang ^b   Wang, Wanchun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interleukin 6; patch clamp recording; spinal cord neurons; voltage gated sodium channels

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; JANUS KINASE; SODIUM CHANNEL NAV1.1; STAT PROTEIN; MESSENGER RNA; VOLTAGE GATED SODIUM CHANNEL; SCN1A PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGICAL PROCEDURES; NERVE ENDING; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD CELL CULTURE; WHOLE CELL PATCH CLAMP; ANIMAL EXPERIMENT; CELL CULTURE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; EXCITABILITY; SODIUM CURRENT; SPIKE; SPINAL CORD NERVE CELL; ACTION POTENTIAL; ANIMAL; DRUG EFFECTS; METABOLISM; NERVE CELL; SPINAL CORD; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; CELLS, CULTURED; INTERLEUKIN-6; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84900319659     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2013.49     Document Type: Article

References (33)

1. GADIENT RA, OTTEN UH. Interleukin-6 (IL-6) - a moleculen with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-390.
2. HOPKINS SJ, ROTHWELL NJ. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 1995;18:83-88.
3. VAN WAGONER NJ, BENVENISTE EN. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999;100: 124-139.
4. KAPLIN AI, DESHPANDE DM, SCOTT E et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115:2731-2741.
5. BRISBY H, OLMARKER K, LARSSON K et al. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 2002;11:62-66.
6. KANEMOTO M. Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase- 1 in human intervertebral disk. Spine 1996;21:1-8.
7. TUNA M, POLAT S, ENNAN T et al. Effect of anti-rat interleukin- 6 antibody after spinal cord injury in the rat: inducible nitric oxide synthase expression, sodium-and potassiumactivated, magnesium-dependent adenosine-5'-triphosphatase and superoxide dismutase activation, and ultrastmetural changes. J Neurosurg 2001;96:64-73.
8. NEUHUBER B, TIMOTHY HIMES B, SHUMSKY JS, GALLO G, FISCHER I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005;1035:73-85.
9. SALLMANN S, JUTTLER E, PRINZ S et al. Induction of interleukin-6 by depolarization of neurons. J Neurosci 2000;20:8637-8642.
10. JONES TB, MCDANIEL EE, POPOVICH PG. Inflammatorymediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 2005;11:1223-1236.
11. CARLSON NG, WIEQQEL WA, CHEN J, BACCHI A, ROQERS SW, GAHRING LC. Inflammatory cytokines IL-1alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 1999;163:3963-3968.
12. LIU Z, QIU YH, LI B et al. Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signaltransduction mechanisms. Neurotox Res 2011;11:484-495.
13. PIZZI M, SARNICO I, BORONI F, BENARESE M, DREANO M, GAROTTA G. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 2004;25:301-311.
14. WANG XQ, PENG YP, LU JH et al. Neuro-protection of interleukin-6 against NMDA attack and its signaltransduction by JAK and MAPK. Neurosci Lett 2009; 450:122-126.
15. HODGKIN AL, HUXLEY AF. A quantitative description of membrane current and its application to induction and excitation in nerve. J Physiol 1952;117:500-544.
16. HILLE B. Ion Channels of Excitable Membranes. Sunderland, MA: Sinauer Associates Inc, 2001.
17. ZHOU C, QI C, ZHAO J et al. Interleukin-1b inhibits voltage-gated sodium currents in a time- and dose-dependent manner in cortical neurons. Neurochem Res 2001;31: 1116-1123.
18. GOLDFARB M, SCHOORLEMMER J, WILLIAMS A et al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron 2007;55:449-463.
19. RUSH AM, DIB-HAJJ SD, LIU S, CUMMINS TR, BLACK JA, WAXMAN SG. A single sodium channel mutation produces hyper-or hypoexcitability in different types of neurons. Proc Natl Acad Sci 2006;103:8245-8250.
20. HAINS BC, SAAB CY, KLEIN JP et al. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004;23: 4832-4839.
21. MOMIN A, WOOD JN. Sensory neuron voltage-gated sodium channels as analgesic drug targets. Curr Opin Neurol 2008;18:383-388.
22. DELOULME JC, BAUDIER J, SENSENBRENNER M. Establishment of pure neuronal cultures from fetal rat spinal cord and proliferation of the neuronal precursor cells in the presence of fibroblast growth factor. J Neurosci Res 1991;29:499-509.
23. NELSON TE, UR CL, GRUOL DL. Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar purkinje neurons in culture. J Neurophysiol 2002;88:475-486.
24. MA SH, LI B, HUANG HW et al. Interleukin-6 inhibits L-type calcium channel activity of cultured cerebellar granule neurons. J Physiol Sci 2012;62:385-392.
25. SPOOREN A, KOLMUS K, LAUREYS G et al. Interleukin-6, a mental cytokine. J Brain Res Rev 2011;67:157-183.
26. ALLAN SM, ROTHWELL NJ. Inflammation in central nervous system injury. Phil Trans R Soc Lond B Biol Sci 2003;358:1669-1677.
27. ALLAN SM, ROTHWELL NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-744.
28. PENG YP, QIU YH, LU JH, WANG JJ. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci Lett 2005;374: 192-196.
29. YANG P, WEN H, OU S et al. IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Exp Neurol 2012;236: 19-27.
30. KANG MK. Kang SKInterleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/ STAT3 pathway with EGF-induced MAPK phosphorylation. Cell Prolif 2008;41:377-392.
31. GEORGENE W, ANTHONY N, J PHILIP M et al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 2010;7:7-19.
32. JABAUDON D, SCANZIANI M, GAÄHWILER BH, GERBER U. Acute decrease in net glutamate uptake during energy deprivation. Proc Natl Acad Sci 2000;97:5610-5615.
33. NISHIZAWA Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001;69:369-381.